rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)

Clinical trial NCT05700591 · COMPLETED

Trial details

NCT number: NCT05700591
Sponsor: Tasly Biopharmaceuticals Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2023-01-29
Primary completion: 2024-03-14
Enrollment: 1552

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.